A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice
Keywords: Inflammatory bowel disease; Nuclear factor kappa B; 5-Aminosalicylic acid (5-ASA); Experimental colitis;